in each of 14 patients with new york heart association class iii or iv congestive heart failure , intravenous milrinone ( mean 57 +/- 5 micrograms/kg ) and placebo were randomly administered just before maximal progressive upright cycle ergometry .
C0018802
congestive heart failure
C0128513
milrinone